Eftilagimod alfa and Keytruda with radiotherapy improved tumor hyalinization/fibrosis rates in resectable soft tissue sarcoma, surpassing the trial's primary endpoint. The combination therapy achieved ...

Results of the study (Utilizing Circulating Tumor DNA to Monitor Sarcoma Treatment and Recurrence) were presented at the 2025 Society of Surgical Oncology (SSO) Annual Meeting in March.

CHARLESTON, S.C. (WCBD) – From now through June 13, the community can give back by getting a haircut to raise money for Sarcoma cancer. Nine independently owned and operated Great Clips ...

Spatial and bulk transcriptomic analysis of skin Kaposi sarcoma lesions: Differences by disease characteristics. Kaposi sarcoma herpesvirus (KSHV) subtypes and impact on survival in 107 patients with ...

Comprehensive molecular analysis of phase IB/II trial of durvalumab plus doxorubicin combination in patients with advanced soft-tissue sarcoma. Change in T2-weighted signal intensity, change in tumor ...

More information: Sharon Pei Yi Chan et al, Functional combinatorial precision medicine for predicting and optimizing soft tissue sarcoma treatments, npj Precision Oncology (2025). DOI: 10.1038 ...

Natera has announced findings from a study evaluating its personalised tumour-informed molecular residual disease (MRD) test, Signatera, in individuals with soft tissue and bone sarcomas.

What is also exciting is the novel drug combination that was identified may supersede existing treatment for soft tissue sarcomas," said Asst Prof Yang. This study marks a pivotal step toward ...

Researchers used precision medicine platform, Quadratic Phenotypic Optimisation Platform (QPOP), to predict treatment response and identify effective drug combinations for soft tissue sarcomas (STS).

The International Federation of Gynecology and Obstetrics (FIGO) staging systems for vulva, cervix, endometrium, and sarcomas have been revised for the first time in over a decade. The purpose of ...